Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul E Polak

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Brain : a Journal of Neurology|February 8, 2011
Locus coeruleus damage and noradrenaline reductions in multiple sclerosis and experimental autoimmune encephalomyelitisPaul E Polak, Sergey Kalinin, Douglas L Feinstein
Journal of Neuroimmunology|September 23, 2014
The blood-brain barrier-permeable catechol-O-methyltransferase inhibitor dinitrocatechol suppresses experimental autoimmune encephalomyelitisPaul E Polak, Shao Xia Lin, Dale Pelligrino, et al.
Journal of Neurochemistry|April 8, 2015
Lanthionine ketimine ester provides benefit in a mouse model of multiple sclerosisJeffrey L Dupree, Paul E Polak, Kenneth Hensley, et al.
Molecular Biology of the Cell|April 11, 2003
ELL and EAF1 are Cajal body components that are disrupted in MLL-ELL leukemiaPaul E Polak, Federico Simone, Joseph J Kaberlein, et al.
Blood|November 26, 2002
ELL-associated factor 2 (EAF2), a functional homolog of EAF1 with alternative ELL binding propertiesFederico Simone, Roger T Luo, Paul E Polak, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|December 4, 2009
Increasing CNS noradrenaline reduces EAE severityMaria Vittoria Simonini, Paul E Polak, Anthony Sharp, et al.
Journal of Neurochemistry|February 1, 2012
The vincamine derivative vindeburnol provides benefit in a mouse model of multiple sclerosis: effects on the Locus coeruleusPaul E Polak, Sergey Kalinin, David Braun, et al.
Journal of Neurochemistry|January 30, 2014
Effects of peptide fraction and counter ion on the development of clinical signs in experimental autoimmune encephalomyelitisAnne I Boullerne, Paul E Polak, David Braun, et al.
Neurobiology of Aging|July 14, 2006
Noradrenaline deficiency in brain increases beta-amyloid plaque burden in an animal model of Alzheimer's diseaseSergey Kalinin, Vitaliy Gavrilyuk, Paul E Polak, et al.
Neurobiology of Aging|June 28, 2011
The noradrenaline precursor L-DOPS reduces pathology in a mouse model of Alzheimer's diseaseSergey Kalinin, Paul E Polak, Shao Xia Lin, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Brain : a Journal of Neurology|February 8, 2011
Locus coeruleus damage and noradrenaline reductions in multiple sclerosis and experimental autoimmune encephalomyelitisPaul E Polak, Sergey Kalinin, Douglas L Feinstein
Journal of Neuroimmunology|September 23, 2014
The blood-brain barrier-permeable catechol-O-methyltransferase inhibitor dinitrocatechol suppresses experimental autoimmune encephalomyelitisPaul E Polak, Shao Xia Lin, Dale Pelligrino, et al.
Journal of Neurochemistry|April 8, 2015
Lanthionine ketimine ester provides benefit in a mouse model of multiple sclerosisJeffrey L Dupree, Paul E Polak, Kenneth Hensley, et al.
Molecular Biology of the Cell|April 11, 2003
ELL and EAF1 are Cajal body components that are disrupted in MLL-ELL leukemiaPaul E Polak, Federico Simone, Joseph J Kaberlein, et al.
Blood|November 26, 2002
ELL-associated factor 2 (EAF2), a functional homolog of EAF1 with alternative ELL binding propertiesFederico Simone, Roger T Luo, Paul E Polak, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|December 4, 2009
Increasing CNS noradrenaline reduces EAE severityMaria Vittoria Simonini, Paul E Polak, Anthony Sharp, et al.
Journal of Neurochemistry|February 1, 2012
The vincamine derivative vindeburnol provides benefit in a mouse model of multiple sclerosis: effects on the Locus coeruleusPaul E Polak, Sergey Kalinin, David Braun, et al.
Journal of Neurochemistry|January 30, 2014
Effects of peptide fraction and counter ion on the development of clinical signs in experimental autoimmune encephalomyelitisAnne I Boullerne, Paul E Polak, David Braun, et al.
Neurobiology of Aging|July 14, 2006
Noradrenaline deficiency in brain increases beta-amyloid plaque burden in an animal model of Alzheimer's diseaseSergey Kalinin, Vitaliy Gavrilyuk, Paul E Polak, et al.
Neurobiology of Aging|June 28, 2011
The noradrenaline precursor L-DOPS reduces pathology in a mouse model of Alzheimer's diseaseSergey Kalinin, Paul E Polak, Shao Xia Lin, et al.
Pageof 3